Director, HCP Marketing - DM1

Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook . Role Summary : The Director, HCP Marketing - DM1, leads the development and execution of HCP-focused strategies and initiatives that empower care providers who treat Myotonic Dystrophy. In an active launch environment, this role is pivotal in driving impactful HCP engagement programs that support successful market entry and long-term adoption. It blends strategic vision with hands-on execution, ensuring Dyne delivers meaningful engagement and education aligned with our mission and brand objectives. You operate with agility to meet critical launch milestones, leverage innovative technologies and omnichannel tactics to maximize educational objectives. Collaboration across Marketing, Medical Affairs, Scientific Affairs, Market Access, and Field Teams is essential to create a cohesive HCP experience from awareness through treatment, while continuously optimizing based on real time insights and launch KPIs. This role is based in Waltham, MA. Primary Responsibilities: HCP Strategy & Launch Execution (in alignment with Brand Strategy) Own HCP strategy and execution for DM1 from pre-launch through launch and beyond; develop and deliver annual HCP plan to drive growth, in alignment with brand strategy set by Brand Lead. Define HCP segmentation and map priority behaviors across stages of adoption; translate insights into sequenced engagement strategies that move HCPs forward, enabled by coordinated messaging and channel optimization. Translate clinical data/label into HCP message strategy and content priorities that support adoption and long-term utilization; provide input into evidence generation priorities to enable sustained differentiation and brand growth. Omnichannel Activation Own the HCP omnichannel engagement strategy across personal and non-personal promotion, defining strategy and priorities, and partnering with omnichannel and analytics engagement teams to execute and optimize across disease-state and branded initiatives. Build closed-loop deployment models to continuously test and learn which messages and channels resonate, detect progression along the belief ladder, and refine journeys accordingly. Ensure HCP digital engagement generates actionable signals that drive next best actions across digital and field channels, in tight coordination with field teams. Cross Functional Leadership Serve as core member of the US Marketing Team, partnering closely with Medical & Scientific Affairs, Market Access, Patient Services, Legal, Regulatory, and Compliance to ensure HCP strategy aligns to the scientific narrative, access realities and patient support model. Provide strategic input into competitive readiness and scenario planning (current and future competitors, data readouts, and pipeline considerations) to grow HCP performance over time. HCP Education, KOL/Peer to Peer, and Congress Lead peer-to-peer education strategy and execution, leveraging modern formats and channels to advance education. Support Regional Market Development Managers as primary field executors for peer-to-peer programming and KOL engagement (e.g., congresses, advisory boards, speaker programs), ensuring strategic alignment, compliant materials and training, and consistent capture of field insights to inform ongoing optimization. Own end-to-end commercial congress strategy for priorit